The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2
|
作者：
Nath, Karthik [1 ]
Mailankody, Sham [1 ,2 ,3 ]
Usmani, Saad Z. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;
D O I：
10.1016/j.hoc.2023.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1201 / 1214
页数：14
相关论文
共 50 条
  • [1] Cardiotoxicities of Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Antibodies
    Qamer, Syed Zyad
    Miraglia, Genie M.
    Granville, Matthew J.
    Finkelstein, Alexa
    Okin, Emily
    Mahmood, Syed Saad
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2024, 26 (07) : 175 - 187
  • [2] Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
    Sassine, Joseph
    Siegrist, Emily A.
    Chemaly, Roy F.
    VIRUSES-BASEL, 2025, 17 (01):
  • [3] Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma
    Mohan, Meera
    Chakraborty, Rajshekhar
    Bal, Susan
    Nellore, Anoma
    Baljevic, Muhamed
    D'Souza, Anita
    Pappas, Peter G.
    Berdeja, Jesus G.
    Callander, Natalie
    Costa, Luciano J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 736 - 746
  • [4] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [5] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [6] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Wang, Zehua
    Chen, Chen
    Wang, Lei
    Jia, Yongxu
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Hosen, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
  • [8] Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
    Navab, Rahul
    Futela, Pragyat
    Kumari, Verkha
    Valecha, Jayesh
    Gupta, Ramansh Bandhu
    Jain, Rohit
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2025, 50 (01) : 1 - 10
  • [9] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [10] Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
    Ahmad, Faizan
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2020, 4 (03): : 179 - 185
12345